Literature DB >> 23733840

Special article: airway management in reconstructive surgery for noma (cancrum oris).

Michael Howard Coupe1, Doug Johnson, Patrick Seigne, Bill Hamlin.   

Abstract

Noma (cancrum oris) is a disease of poverty and malnutrition, which predominantly affects children younger than 10 years in developing countries. Although the majority of sufferers die of sepsis at the time of the initial infection, or of subsequent starvation due to severe trismus and an inability to eat, a small minority of patients survive and require reconstructive surgery for severe facial scarring and deformity. These patients present significant problems to the anesthesiologist with regard to airway management. We present a series of 26 patients undergoing primary and subsequent reconstructive surgery, with particular focus on airway management. We show that airway management, while challenging, can be performed safely and successfully by using individualized airway plans but may require advanced techniques and equipment. Traditional tests focusing on the anterior/superior airway are helpful in assessing patients with facial deformity due to noma.

Entities:  

Mesh:

Year:  2013        PMID: 23733840     DOI: 10.1213/ANE.0b013e3182908e6f

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

Review 1.  Tropical Medicine and Anaesthesia; part 2.

Authors:  T Bashford; V Howell
Journal:  BJA Educ       Date:  2018-01-20

Review 2.  Noma (cancrum oris): An unresolved global challenge.

Authors:  Liviu Feller; Razia A G Khammissa; Mario Altini; Johan Lemmer
Journal:  Periodontol 2000       Date:  2019-06       Impact factor: 7.589

Review 3.  A retrospective clinical, multi-center cross-sectional study to assess the severity and sequela of Noma/Cancrum oris in Ethiopia.

Authors:  Heron Gezahegn Gebretsadik; Laurent Cleenewerck de Kiev
Journal:  PLoS Negl Trop Dis       Date:  2022-09-13

4.  Facing Africa: Describing Noma in Ethiopia.

Authors:  Alexander J Rickart; Will Rodgers; Kelvin Mizen; Graham Merrick; Paul Wilson; Hiroshi Nishikawa; David J Dunaway
Journal:  Am J Trop Med Hyg       Date:  2020-04-30       Impact factor: 2.345

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.